Human Investing LLC Vertex Pharmaceuticals Inc Transaction History

Human Investing LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$187.49 - $221.1 $3,749 - $4,422	-20 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$255.65 - $303.1 $27,098 - $32,128	-106 Reduced 84.13%	20 $5,000
Q2 2020 Jul 22, 2020	BUY	$225.48 - $295.8 $23,900 - $31,354	106 Added 530.0%	126 $37,000
Q1 2020 Apr 22, 2020	SELL	$199.77 - $247.81 $23,572 - $29,241	-118 Reduced 85.51%	20 $5,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $19,671 - $26,421	118 Added 590.0%	138 $30,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $3,038 - $3,844	20 New	20 $3,000

1,708

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

Stay updated on Human Investing LLC with notifications on news.